Natalie Yivgi-Ohana is CEO at Minovia Therapeutics which develops mitochondria augmentation therapies for rare mitochondrial diseases, as well as studies two of the hallmarks of aging: stem cells and mitochondrial dysfunction, and develops therapies based on mitochondria augmentation in hematopoietic stem cells. She has filed for patents to protect the following inventions. This listing includ...